Axillary surgery trial for breast cancer
Completed
- Conditions
- CancerBreast cancerMalignant neoplasm of the breast
- Registration Number
- ISRCTN88463711
- Lead Sponsor
- K Co-ordinating Committee for Cancer Research (UKCCCR)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 0
Inclusion Criteria
1. Histologically proven breast cancer
2. Tumour size no greater than 4 cm
3. No skin involvement
4. Aged less than 70 years
5. No medical contraindications to treatment protocols
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie axillary lymph node dissection in breast cancer recurrence prevention?
How does axillary surgery in ISRCTN88463711 compare to sentinel node biopsy for breast cancer survival outcomes?
Which biomarkers correlate with improved prognosis after axillary surgery in triple-negative breast cancer patients?
What are the long-term lymphedema risks associated with axillary dissection in ISRCTN88463711 breast cancer trial?
Are there combination therapies with axillary surgery for breast cancer in ISRCTN88463711 and neoadjuvant chemotherapy?